Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
University of Chicago
University of Chicago
University of Miami
City of Hope Medical Center
Rutgers, The State University of New Jersey
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
University of Iowa
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
University of Nebraska
Washington University School of Medicine
Dana-Farber Cancer Institute
Thomas Jefferson University
Barbara Ann Karmanos Cancer Institute
Hackensack Meridian Health
The Netherlands Cancer Institute
University of Nebraska
University Hospital, Ghent
RTOG Foundation, Inc.
University of California, Davis
Virginia Commonwealth University
University of California, San Diego
Memorial Sloan Kettering Cancer Center
Virginia Commonwealth University
University Health Network, Toronto
University of Texas Southwestern Medical Center
Cedars-Sinai Medical Center
Fox Chase Cancer Center
Fox Chase Cancer Center
Abramson Cancer Center at Penn Medicine
Ohio State University Comprehensive Cancer Center
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Masonic Cancer Center, University of Minnesota
University of Pittsburgh
M.D. Anderson Cancer Center
Massachusetts General Hospital
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
AHS Cancer Control Alberta
AHS Cancer Control Alberta
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
AHS Cancer Control Alberta
City of Hope Medical Center